Skip to Main Content

Paper Details

Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation.
BMC Cancer
4
2022
Author NameAffiliation
Terry M TherneauDivision of Clinical Trials and Biostatistics, Mayo Clinic College of Medicine and Science
Lewis R RobertsMayo Clinic College of Medicine and Science
  • 1 - 2

Datasets

Release 1.2